Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2009 Feb;26(6):493-8.
doi: 10.1159/000229784. Epub 2010 Jan 14.

Clinical Study on Combined Therapy of Botulinum Toxin Injection and Small Balloon Dilation in Patients With Esophageal Achalasia

Randomized Controlled Trial

Clinical Study on Combined Therapy of Botulinum Toxin Injection and Small Balloon Dilation in Patients With Esophageal Achalasia

Qiang Zhu et al. Dig Surg. .


Background and study aims: To compare the efficiency of pneumatic balloon dilation, botulinum toxin (BT) injection, and the combination of the two modalities in the management of esophageal achalasia.

Patients and methods: Ninety patients with esophageal achalasia were randomly divided into three groups according to different interventions, i.e. patients in group A received 100 U BT injection; patients in group B were given balloon dilation, and patients in group C were subjected to balloon dilation plus 100 U BT injection 15 days after the dilation. Clinical assessment and esophageal manometry were performed by experienced gastroenterologists. All patients were followed-up for more than 2 years.

Results: At any time after the treatment, the lower esophageal sphincter pressure and symptom score in group C were lower compared with those in group A or group B (p < 0.05). At 2 years after treatment, the response rate in group C remained 56.67%, still higher than those in the other groups (p < 0.05); the response rate in group B was only 35.71% (10/28); the response rate in group A was 13.79%, the lowest among the three groups.

Conclusions: The efficiency of the combination of 100 U BT administration and small balloon dilation is superior to the single modality approach.

Comment in

Similar articles

See all similar articles

Cited by 7 articles

  • 2019 Seoul Consensus on Esophageal Achalasia Guidelines.
    Jung HK, Hong SJ, Lee OY, Pandolfino J, Park H, Miwa H, Ghoshal UC, Mahadeva S, Oshima T, Chen M, Chua ASB, Cho YK, Lee TH, Min YW, Park CH, Kwon JG, Park MI, Jung K, Park JK, Jung KW, Lim HC, Jung DH, Kim DH, Lim CH, Moon HS, Park JH, Choi SC, Suzuki H, Patcharatrakul T, Wu JCY, Lee KJ, Tanaka S, Siah KTH, Park KS, Kim SE; Korean Society of Neurogastroenterology and Motility. Jung HK, et al. J Neurogastroenterol Motil. 2020 Apr 30;26(2):180-203. doi: 10.5056/jnm20014. J Neurogastroenterol Motil. 2020. PMID: 32235027 Free PMC article. Review.
  • Bridging therapy for achalasia in a second trimester pregnant patient.
    Neubert ZS, Stickle ET. Neubert ZS, et al. J Family Med Prim Care. 2019 Jan;8(1):289-297. doi: 10.4103/jfmpc.jfmpc_389_18. J Family Med Prim Care. 2019. PMID: 30911523 Free PMC article.
  • Clinical management of achalasia: current state of the art.
    Krill JT, Naik RD, Vaezi MF. Krill JT, et al. Clin Exp Gastroenterol. 2016 Apr 4;9:71-82. doi: 10.2147/CEG.S84019. eCollection 2016. Clin Exp Gastroenterol. 2016. PMID: 27110134 Free PMC article. Review.
  • Endoscopic treatment of esophageal achalasia.
    Esposito D, Maione F, D'Alessandro A, Sarnelli G, De Palma GD. Esposito D, et al. World J Gastrointest Endosc. 2016 Jan 25;8(2):30-9. doi: 10.4253/wjge.v8.i2.30. World J Gastrointest Endosc. 2016. PMID: 26839644 Free PMC article.
  • Pharmacotherapy for the management of achalasia: Current status, challenges and future directions.
    Nassri A, Ramzan Z. Nassri A, et al. World J Gastrointest Pharmacol Ther. 2015 Nov 6;6(4):145-55. doi: 10.4292/wjgpt.v6.i4.145. World J Gastrointest Pharmacol Ther. 2015. PMID: 26558149 Free PMC article. Review.
See all "Cited by" articles

Publication types